Join the Class Action Against Nutex Health Inc. for Compensation Recovery

Nutex Health Inc. Class Action Update

Overview

In recent news, Levi & Korsinsky, LLP has informed investors of Nutex Health Inc. (NASDAQ: NUTX) about a class action lawsuit seeking to recover losses due to alleged securities fraud that occurred between August 8, 2024, and August 14, 2025. If you have suffered a loss on your investment in Nutex Health during this period, it is vital to understand your rights and the steps you can take.

Class Action Details

The class action lawsuit aims to recover damages for investors adversely affected by the actions of Nutex Health Inc. The allegations against the company include deceptive practices and the concealment of critical information that significantly impacted the financial well-being of its investors. Specifically, the lawsuit argues that the management made false statements and failed to disclose that:

1. HaloMD, a third-party vendor, was involved in fraudulent activities that misled insurance companies and inflated Nutex's revenues.
2. These claimed revenues were not sustainable, leading to overstated financial prospects for Nutex Health.
3. The company underreported material weaknesses in their internal controls concerning financial reporting, jeopardizing the accuracy of their financial statements.
4. There were serious miscalculations in stock-based compensation, which were improperly classified in financial reports.
5. The aforementioned issues placed the company at risk of not meeting deadlines for filing reports with the SEC, further misleading investors about the company's financial health.

These allegations culminate in a situation where public statements made by Nutex Health were deemed materially false and misleading, affecting investor decisions and resulting in financial losses.

Your Rights as an Investor

If you were an investor in Nutex Health during the specified period, you have rights, and your participation in this class action could potentially yield compensation without incurring any out-of-pocket expenses. The timeframe to join this action is crucial, as investors can request to be appointed as lead plaintiff until October 21, 2025. However, it’s important to note that you can still recover even if you don't wish to take on the lead role.

Next Steps

To learn more about this lawsuit or if you wish to participate, interested investors can visit the following link for further details: Class Action Information or contact Joseph E. Levi, Esq. directly via email ([email protected]) or by phone at (212) 363-7500.

Why Choose Levi & Korsinsky?

Levi & Korsinsky has over two decades of experience in successfully representing shareholders in complex securities litigation. Their proven track record includes securing hundreds of millions in compensation for aggrieved investors, showcasing an exceptional capability in handling high-stakes cases. For seven years in a row, they have earned a commendable place in ISS Securities Class Action Services' list of Top 50 Report as one of the leading firms in the U.S. for securities litigation.

Contact Information

For any inquiries or to participate in the class action, reach out to Levi & Korsinsky at:

- Address: 33 Whitehall Street, 17th Floor, New York, NY 10004
- Phone: (212) 363-7500
- Email: [email protected]

Being informed about these developments is crucial for investors affected by Nutex Health Inc.'s alleged malpractices. Joining the class action lawsuit represents a proactive step towards seeking justice and potential recovery.